Literature DB >> 23355686

No REST for fibroids.

Bo R Rueda1, John S Davis.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23355686      PMCID： PMC3568368          DOI： 10.1073/pnas.1222730110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  18 in total

1.  Differential expression of Akt/protein kinase B, Bcl-2 and Bax proteins in human leiomyoma and myometrium.

Authors:  Kálmán A Kovács; Ferenc Lengyel; József L Környei; Zsuzsanna Vértes; István Szabó; Balázs Sümegi; Marietta Vértes
Journal:  J Steroid Biochem Mol Biol       Date:  2003-12       Impact factor: 4.292

2.  Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines.

Authors:  Xuejun J Yin; Gangduo Wang; Firyal S Khan-Dawood
Journal:  Am J Obstet Gynecol       Date:  2007-02       Impact factor: 8.661

3.  NRSF/REST confers transcriptional repression of the GPR10 gene via a putative NRSE/RE-1 located in the 5' promoter region.

Authors:  Daniel M Kemp; Julia C Lin; Mariano Ubeda; Joel F Habener
Journal:  FEBS Lett       Date:  2002-11-06       Impact factor: 4.124

Review 4.  Medical treatment of uterine leiomyoma.

Authors:  Mohamed Sabry; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2012-02-28       Impact factor: 3.060

5.  A prolactin-releasing peptide in the brain.

Authors:  S Hinuma; Y Habata; R Fujii; Y Kawamata; M Hosoya; S Fukusumi; C Kitada; Y Masuo; T Asano; H Matsumoto; M Sekiguchi; T Kurokawa; O Nishimura; H Onda; M Fujino
Journal:  Nature       Date:  1998-05-21       Impact factor: 49.962

Review 6.  The estimated annual cost of uterine leiomyomata in the United States.

Authors:  Eden R Cardozo; Andrew D Clark; Nicole K Banks; Melinda B Henne; Barbara J Stegmann; James H Segars
Journal:  Am J Obstet Gynecol       Date:  2011-12-11       Impact factor: 8.661

Review 7.  Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implications.

Authors:  Pasquapina Ciarmela; Md Soriful Islam; Fernando M Reis; Peter C Gray; Enrrico Bloise; Felice Petraglia; Wylie Vale; Mario Castellucci
Journal:  Hum Reprod Update       Date:  2011-07-25       Impact factor: 15.610

8.  Comparison of human and rat uterine leiomyomata: identification of a dysregulated mammalian target of rapamycin pathway.

Authors:  Judy S Crabtree; Scott A Jelinsky; Heather A Harris; Sung E Choe; Monette M Cotreau; Michelle L Kimberland; Ewa Wilson; Kathryn A Saraf; Wei Liu; Adrienne S McCampbell; Bhuvanesh Dave; Russell R Broaddus; Eugene L Brown; Wenling Kao; Jerauld S Skotnicki; Magid Abou-Gharbia; Richard C Winneker; Cheryl L Walker
Journal:  Cancer Res       Date:  2009-07-21       Impact factor: 12.701

9.  The antidiabetic drug metformin inhibits uterine leiomyoma cell proliferation via an AMP-activated protein kinase signaling pathway.

Authors:  Bin Li; Takashi Takeda; Kenji Tsuiji; Akiko Kondo; Mari Kitamura; Tze Fang Wong; Nobuo Yaegashi
Journal:  Gynecol Endocrinol       Date:  2012-07-26       Impact factor: 2.260

10.  Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells.

Authors:  Linda Yu; Alicia B Moore; Lysandra Castro; Xiaohua Gao; Hoang-Long C Huynh; Michelle Klippel; Norris D Flagler; Yi Lu; Grace E Kissling; Darlene Dixon
Journal:  J Signal Transduct       Date:  2012-10-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.